87
Views
15
CrossRef citations to date
0
Altmetric
Review

Antisense and small-molecule modulation of diacylglycerol acyltransferase

, , &
Pages 1331-1339 | Published online: 09 Nov 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vishal P. Zambre, Shamali M. Khamkar, Dnyaneshwar D. Gavhane, Sagar C. Khedkar, Monali R. Chavan, Madhuri M. Pandey, Sonali B. Sanap, Rajesh B. Patil & Sanjay D. Sawant. (2020) Patent landscape for discovery of promising acyltransferase DGAT and MGAT inhibitors. Expert Opinion on Therapeutic Patents 30:11, pages 873-896.
Read now
Andrew J King, Andrew S Judd & Andrew J Souers. (2010) Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents. Expert Opinion on Therapeutic Patents 20:1, pages 19-29.
Read now

Articles from other publishers (13)

Jianwei Yan, Gaihong Wang, Xiangyu Dang, Binbin Guo, Wuhong Chen, Ting Wang, Limin Zeng, Heyao Wang & Youhong Hu. (2017) Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety. Bioorganic & Medicinal Chemistry 25:17, pages 4701-4714.
Crossref
Katsumasa Nakajima, Ricardo Chatelain, Kevin B. Clairmont, Renee Commerford, Gary M. Coppola, Thomas Daniels, Cornelia J. Forster, Thomas A. Gilmore, Yongjin Gong, Monish Jain, Aaron Kanter, Youngshin Kwak, Jingzhou Li, Charles D. Meyers, Alan D. Neubert, Paul Szklennik, Vivienne Tedesco, James Thompson, David Truong, Qing Yang, Brian K. Hubbard & Michael H. Serrano-Wu. (2017) Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans. Journal of Medicinal Chemistry 60:11, pages 4657-4664.
Crossref
Katsumasa Nakajima, Myriam April, Jason T. Brewer, Thomas Daniels, Cornelia J. Forster, Thomas A. Gilmore, Monish Jain, Aaron Kanter, Youngshin Kwak, Jingzhou Li, Les McQuire, Michael H. Serrano-Wu, Ryan Streeper, Paul Szklennik, James Thompson & Bing Wang. (2016) Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1245-1248.
Crossref
Jian-Peng Yin, Min Gu, Ying Li & Fa-Jun Nan. (2014) Total Synthesis of Aphadilactones A–D. The Journal of Organic Chemistry 79:13, pages 6294-6301.
Crossref
Brian M. Fox, Kazuyuki Sugimoto, Kiyosei Iio, Atsuhito Yoshida, Jian (Ken) Zhang, Kexue Li, Xiaolin Hao, Marc Labelle, Marie-Louise Smith, Steven M. Rubenstein, Guosen Ye, Dustin McMinn, Simon Jackson, Rebekah Choi, Bei Shan, Ji Ma, Shichang Miao, Takuya Matsui, Nobuya Ogawa, Masahiro Suzuki, Akio Kobayashi, Hidekazu Ozeki, Chihiro Okuma, Yukihito Ishii, Daisuke Tomimoto, Noboru Furakawa, Masahiro Tanaka, Mutsuyoshi Matsushita, Mitsuru Takahashi, Takashi Inaba, Shoichi Sagawa & Frank Kayser. (2014) Discovery of 6-Phenylpyrimido[4,5- b ][1,4]oxazines as Potent and Selective Acyl CoA:Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors with in Vivo Efficacy in Rodents . Journal of Medicinal Chemistry 57:8, pages 3464-3483.
Crossref
Alleyn T. Plowright, Peter Barton, Stuart Bennett, Alan M. Birch, Susan Birtles, Linda K. Buckett, Roger J. Butlin, Robert D. M. Davies, Anne Ertan, Pablo Morentin Gutierrez, Paul D. Kemmitt, Andrew G. Leach, Per H. Svensson, Andrew V. Turnbull & Michael J. Waring. (2013) Design and synthesis of a novel series of cyclohexyloxy-pyridyl derivatives as inhibitors of diacylglycerol acyl transferase 1. MedChemComm 4:1, pages 151-158.
Crossref
Kyeong Lee, Ja-Il Goo, Hwa Young Jung, Minkyoung Kim, Shanthaveerappa K. Boovanahalli, Hye Ran Park, Mun-Ock Kim, Dong-Hyun Kim, Hyun Sun Lee & Yongseok Choi. (2012) Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:24, pages 7456-7460.
Crossref
William McCoull, Matthew S. Addie, Alan M. Birch, Susan Birtles, Linda K. Buckett, Roger J. Butlin, Suzanne S. Bowker, Scott Boyd, Stephen Chapman, Robert D.M. Davies, Craig S. Donald, Clive P. Green, Chloe Jenner, Paul D. Kemmitt, Andrew G. Leach, Graeme C. Moody, Pablo Morentin Gutierrez, Nicholas J. Newcombe, Thorsten Nowak, Martin J. Packer, Alleyn T. Plowright, John Revill, Paul Schofield, Chris Sheldon, Steve Stokes, Andrew V. Turnbull, Steven J.Y. Wang, David P. Whalley & J. Matthew Wood. (2012) Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. Bioorganic & Medicinal Chemistry Letters 22:12, pages 3873-3878.
Crossref
Michael H. Serrano-Wu, Gary M. Coppola, Yongjin Gong, Alan D. Neubert, Ricardo Chatelain, Kevin B. Clairmont, Renee Commerford, Theresa Cosker, Thomas Daniels, Ying Hou, Monish Jain, Marlene Juedes, Lisha Li, Tara Mullarkey, Erik Rocheford, Moo Je Sung, Andrew Tyler, Qing Yang, Taeyoung Yoon & Brian K. Hubbard. (2012) Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides. ACS Medicinal Chemistry Letters 3:5, pages 411-415.
Crossref
Matthew M. RavnSeble H. WagawKenneth M. EngstromJianzhang MeiBrian KoteckiAndrew J. SouersPhilip R. KymAndrew S. JuddGang Zhao. (2010) Process Development of a Diacyl Glycerolacyltransferase-1 Inhibitor. Organic Process Research & Development 14:2, pages 417-424.
Crossref
Paulo J. Magalhães, Daniel O. Carvalho, José M. Cruz, Luís F. Guido & Aquiles A. Barros. (2009) Fundamentals and Health Benefits of Xanthohumol, a Natural Product Derived from Hops and Beer. Natural Product Communications 4:5, pages 1934578X0900400.
Crossref
Alan M. Birch, Susan Birtles, Linda K. Buckett, Paul D. Kemmitt, Graham J. Smith, Tim J. D. Smith, Andrew V. Turnbull & Steven J. Y. Wang. (2009) Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor. Journal of Medicinal Chemistry 52:6, pages 1558-1568.
Crossref
Victor A. Zammit, Linda K. Buckett, Andrew V. Turnbull, Haja Wure & Andrew Proven. (2008) Diacylglycerol acyltransferases: Potential roles as pharmacological targets. Pharmacology & Therapeutics 118:3, pages 295-302.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.